Mikhail Blagosklonny Uses Oncotarget to Address Medical Issues

As a leading cause of morbidity as well as mortality in the world, cancer has been a threat to the medical fraternity. The new cases of death caused by cancer have risen to approximately 70% over the past decades. In order to deal with the cases of death caused by cancer, scientists, researchers as well as donors from different walks of life have converged their ideas with the aim of generating therapies that have a curative nature. The main objective of coming together is coming up with solutions. One such scientist who has been instrumental in the battle against cancer and age-related diseases is Mikhail Blagosklonny.

Experience

As an expert in cancer biology as well as treatment therapies, Mikhail has been developing different therapies with the aim of reaching out to the affected patients. Coupled with a strong academic background, Mikhail has explored different treatment options thanks to his extensive experience in research. Through his experiences, he has been able to develop successful therapies. Blagosklonny has proven to the medical field that modern treatment methods can be implemented to cure diseases. Most of his therapies have brought forth revolutionary treatment options.

Research

Blagosklonny is a research scientist and renowned oncologist who has made a name for himself in the medical field. He is prominent for having authored and co-authored many book chapters. He has also authored over 170 articles concerning cancer as well as age-related diseases. The topics of discussion include the generation of cancer cells and their progressive mutation in the host. This topic covers their cycle as well as apoptosis and autophagy. Blagosklonny’s works focus on the theory of aging called target of rapamycin.

TOR

Also abbreviated as TOR Signaling, Blagosklonny states that this theory plays an instrumental role in the treatment of cancer. It prolongs life by delaying autophagy as well as promoting cellular synthesis of proteins. This process is important because it slows down the aging process of human cells. This in turn curbs age-related diseases. In the same scenario, Blagosklonny proved that the over- expression of target of rapamycin would inhibit autophagy. This in turn leads to the growth of cancerous tumors. To Blagosklonny, it is vital to understand the entire process of autophagy. This is because with a clear understanding, it is easy to administer treatment.

Education and Career

Aside from being a research scientist, Mikhail Blagosklonny is a scholar. His experience extends beyond basic research. He presently serves as a professor at the Institute of Roswell Park, a cancer research institute. He has been serving in that institution since 2009. In 2002, Blagosklonny was appointed as a lead specialist in experimental as well as internal medicine. This saw his appointment as an associate professor at the New York College of Medical Studies. As an alumnus of the University of First Pavlov, he has a lot of achievement to show for his experience. Presently, he is the chief editor of Oncotarget. This is a peer-reviewed journal that addresses scientific issues related to various medical journals. Through Oncotarget, Blagosklonny has addressed various medical issues in regards to cancer and its treatment.

The Impressive Resume of Eric Lefkofsky

A respected business man and entrepreneur, Eric Lefkofsky has made a major impact on the business world while also making a big name for himself during his career. He is responsible for founding Tempus, a technology company where he is also the CEO. Lefkofsy has had his hand in several businesses and has showcased his ability to start and build a businesses.

Lefkofsky is Michigan native. During his youth he watch both of his parents work extremely hard. His mom Sandy, was a school teacher and his dad Bill, worked as a structural engineer. They modeled for him the value of hard work and determination. Lefkofsky would follow their lead by attending the University of Michigan where he earned a degree with honors in 1991. Just two years later he would earn arhighlyespectedJuris Doctor from the University of Michigan Law School.

Soon after earning his degree Eric Lefkofsky entered into life as a businessman. He started this experiment by collaborating with a long time friend Brad Keywell. With little money to start, the duo borrowed money to start their first company Brandon Apparel, a Wisconsin based apparel company. These two entrepreneurs would have great success with their company. Soon they would start a variety of other move on to businesses including Echo Global, Mediabank and Starbelly. In 1999, it was the Internet companycalled Starbelly that started their experimenting. This tech based comapny specialized in promotional products. Soon after Starbelly, Lefkofsky, co-founded InnerWorkings, a company that provided print procurement services.

Just years later Lefkofsky would start his most successful business yet. He would provided more than one million dollars in funding for the website website ThePoint.com. This little known site would soon change he world. It is known today by the more familiar Groupon.com. The site would have massive success even fielding offers of several billion dollars from the likes of google.

Eric Lefkofsky had produced an impressive resume over the years. He clearly understands what it takes to have success in business. With his experience and strong determination, he is sure to be around for many more years to come.

About Eric Lefkofsky: www.tempus.com/about-us/